Danaher Work in process increased by 0.2% to $526.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 5.6%, from $498.00M to $526.00M. Over 4 years (FY 2020 to FY 2024), Work in process shows an upward trend with a 6.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $433.00M | $465.00M | $473.00M | $530.00M | $530.00M | $519.00M | $473.00M | $542.00M | $528.00M | $497.00M | $459.00M | $509.00M | $491.00M | $498.00M | $465.00M | $517.00M | $525.00M | $526.00M |
| QoQ Change | — | +7.4% | +1.7% | +12.1% | +0.0% | -2.1% | -8.9% | +14.6% | -2.6% | -5.9% | -7.6% | +10.9% | -3.5% | +1.4% | -6.6% | +11.2% | +1.5% | +0.2% |
| YoY Change | — | — | — | — | +22.4% | +11.6% | +0.0% | +2.3% | -0.4% | -4.2% | -3.0% | -6.1% | -7.0% | +0.2% | +1.3% | +1.6% | +6.9% | +5.6% |
| % of Inventories | 17.0% | 17.0% | 17.1% | 17.3% | 16.3% | 16.0% | 15.2% | 16.0% | 16.6% | 16.4% | 17.7% | 19.2% | 18.4% | 18.6% | 20.0% | 20.4% | 19.5% | 19.7% |
| Share Change | — | -0.0pp | +0.1pp | +0.2pp | -1.0pp | -0.2pp | -0.8pp | +0.8pp | +0.6pp | -0.2pp | +1.3pp | +1.5pp | -0.9pp | +0.2pp | +1.4pp | +0.5pp | -0.9pp | +0.1pp |
We use cookies for analytics. See our Privacy and Cookie Policy.